Emulsion of Chloramphenicol: an Overwhelming Approach for Ocular Delivery

Kalpesh C. Ashara 1  and Ketan V. Shah 1
  • 1 School of Pharmacy, RK University, Rajkot-Bhavnagar highway, Rajkot, Gujarat 360020, India

Abstract

Background: Ophthalmic formulations of chloramphenicol have poor bioavailability of chloramphenicol in the ocular cavity.

Aim: The present study aimed at exploring the impact of different oil mixtures in the form of emulsion on the permeability of chloramphenicol after ocular application.

Materials and methods: Selection of oil mixture and ratio of the components was made by an equilibrium solubility method. An emulsifier was chosen according to its emulsification properties. A constrained simplex centroid design was used for the assessment of the emulsion development. Emulsions were evaluated for physicochemical properties; zone of inhibition, in-vitro diffusion and ex-vivo local accumulation of chloramphenicol. Validation of the design using check-point batch and reduced polynomial equations were also developed. Optimization of the emulsion was developed by software Design® expert 6.0.8. Assessment of the osmolarity, ocular irritation, sterility testing and isotonicity of optimized batch were also made.

Results: Parker Neem®, olive and peppermint oils were selected as an oil phase in the ratio 63.64:20.2:16.16. PEG-400 was selected as an emulsifier according to a pseudo-ternary phase diagram. Constrained simplex-centroid design was applied in the range of 25-39% water, 55-69% PEG-400, 5-19% optimized oil mixture, and 1% chloramphenicol. Unpaired Student’s t-test showed for in-vitro and ex-vivo studies that there was a significant difference between the optimized batch of emulsion and Chloramphenicol eye caps (a commercial product) according to both were equally safe.

Conclusion: The optimized batch of an emulsion of chloramphenicol was found to be as safe as and more effective than Chloramphenicol eye caps.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Iwalokun BA, Oluwadun A, Akinsinde KA. Bacteriologic and plasmid analysis of etiologic agents of conjunctivitis in Lagos, Nigeria. J Ophthal Infl amm Infect 2011;1:95-103.

  • 2. Flores-Páez LA, Alcántar-Curiel MD, Mendoza CF, et al. Molecular and phenotypic characterization of staphylococcus epidermidis isolates from healthy conjunctiva and a comparative analysis with isolates from ocular infection. PLoS One 2015;10(8):e0135964.

  • 3. Hi-Media. Product information of chloramphenicol. [Cited September, 2015].

  • 4. Reddy MC, Firoz S, Rajalakshmi R, et al. Design and evaluation of chloramphenicol thermo reversible in-situ gels for ocular drug delivery. Int J Inn Pharm Res 2011;2(2):131-8.

  • 5. Tadros TF, Schramm LL, Aserin A. Emulsion Science and Technology. Vol. 1, Chapter 1, GmBH: Willey VCH, 2009, 1-55.

  • 6. Chen Y, Liu X, Wang M, et al. Novel chemical permeation enhancers for transdermal drug delivery. Asia J Pharm Sci 2014;9(2014):51-64.

  • 7. Product Information of Chloramphenicol, in Cayman Chemical. USA [Cited September, 2015].

  • 8. Horven I. Acute conjunctivitis: A comparison of fusidic acid viscous eye drops and chloramphenicol. Act Ophthal 1993;71:165-8.

  • 9. Mori NM, Patel PV, Sheth NR. Fabrication & characterization of Voriconazole transdermal spray for treatment of fungal infection. [M. Pharm. Thesis], Rajkot, India, Saurashtra University, 2013.

  • 10. Andonova V, Georgiev G, Toncheva V, et al. Indomethacin loading and in vitro release properties from vinyl acetate homo- and co-polymer nanoparticles, coated with polyzwitterion and carbopol® shells. Int J Pharm Pharm Sci 2014;6(1):691-9.

  • 11. Thakkar H, Nangesh J, Parmar M. Formulation and characterization of lipid based drug delivery system of raloxifene micro-emulsion and self-micro-emulsifying drug delivery system. J Pharm Bio Allied Sci 2011;3(3):442-8.

  • 12. Baboota S, Ahuja A, Shafi q JS, et al. Design, development and evaluation of novel nano-emulsion formulations for transdermal potential of celecoxib. Act Pharm 2007;57:315-32.

  • 13. Patel VP, Sihora HD. Experimental Design & Patents. 1st Ed, Ahmedabad; 2012; Akshat Publications & distributors, 105-17.

  • 14. Mandera HP, Bhimani DR. Formulation, development and characterization of quetiapine fumarate loaded intranasal micro-emulsion. [M.Pharm. Thesis], Ahmedabad, India, Gujarat Technology University, 2014.

  • 15. Badawi AA, Nour SA, Sakran WS, et al. Preparation and evaluation of micro-emulsion systems containing salicylic acid. AAPS Pharm SciTech 2009;10(4):1081-4.

  • 16. Saha DS. To determine the viscosity of a given unknown liquid with respect to water, at laboratory temperature, by viscometer. [B. Pharm. Thesis], Mumbai, India, BHU; 2013.

  • 17. Madikattu K, Srisailam K. Microemulsion based transdermal gels of isradipine to enhance bioavailability: in-vitro and in-vivo evaluation. Asi J Pharm 2016;9(5):S23-30.

  • 18. Teku RL, Mylangam CK, Kolapalli VM, et al. Formulation of capsaicin loaded emulgels using natural gums and oils for topical delivery. Wor J Pharm Pharma Sci 2015;5(1):1017-34.

  • 19. Hamishehkar H, Khoshbakht M, Jouyban A. The relationship between solubility and transdermal absorption of Tadalafi l. Adv Pharm Bull 2015;3(2):411-7.

  • 20. Srinivas P, Sreeja K. Formulation and evaluation of voriconazole loaded nanosponges for oral and topical delivery. Int J Drug Dev & Res 2013;5(1):55-69.

  • 21. Government of India Ministry of Health and Family Welfare. Indian Pharmacopoeia. 6th ed. Ghaziabad, the Indian Pharmacopoeia Commission, 2010.

  • 22. El-Hadidy GN, Ibrahim HK, Mohamed MI, et al. Micro-emulsion as vehicle for topical administration of voriconazole: formulation and in-vitro evaluation. Dru Dev Ind Pharm 2012;38(1):64-72.

  • 23. Basera K, Kothiyal P, Gupta P. Nanoemulgel: a novel formulation approach for topical delivery of hydrophobic drugs. World Journal of Pharmacy and Pharmaceutical Sciences 2015;4(10):1871-86.

  • 24. Jain A, Gautam SP, Gupta Y, et al. Development and characterization of ketoconazole emulgel for topical drug delivery. Der Pharm Sin 2010;1(3):221-31.

  • 25. Ashara KC, Paun JS, Soniwala MM, et al. Microemulsion based emulgel: a novel topical drug delivery system. Asian Pac J Trop Dis 2014;04 (Supl 1):S27-32.

  • 26. www.mathcentre.ac.uk, Abi Francis UA-KaBM. Pharmacy calculations II: Isotonicity Liverpool: John Moores University; [Cited May, 2016]

  • 27. Andonova V, Zagorchev P, Katsarov P, et al. Eye drops with nanoparticles as drug delivery systems. Int J Pharm Pharm Sci 2015;17(2):431-5.

  • 28. Gohel MC, Nagori SA. Fabrication of modifi ed transport fl uconazole transdermal spray containing ethyl cellulose and eudragit® RS100 as fi lm formers. AAPS Pharm SciTech 2009;10(02):684-91.

  • 29. Jain S. Expert opinion on sheep or goat cornea. In: Ashara KC, ed., 2016, 1-2.

  • 30. Ashara KC, Shah KV. Cow’s urine: an incredible aqueous phase. Glob J Biotech Biochem 2016;11(2):145-52.

  • 31. Andonova V, Georgiev G, Toncheva V, et al. Carbopol ® and chitosan coated nanoparticles with in-situ loaded indomethacin. Am J PharmTech Res 2014;4(1):664-8.

OPEN ACCESS

Journal + Issues

Search